News

Immix Biopharma, Inc. (IMMX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...
The first thing to understand about Dollar General's rise is that it's only a partial rebound from a much steeper decline. The stock is still down roughly 57% from its 2022 high-water mark. That's one ...
Telenor (TELNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Orla Mining Ltd. (ORLA) could be a solid addition to your portfolio given a notable revision in the company's earnings ...
Skyward Specialty Insurance (SKWD) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings ...
The stock has been trading around $18 - $21 per ... trends and chart patterns to estimate future price movements. Fundamental analysis dives into the company’s financials – think revenue ...